ArticleJACC. Case reports2026
Resuscitated Cardiac Arrest From Cardiac Sarcoidosis in a Professional Basketball Player: A Slam Dunk Diagnosis?
Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCardiac sarcoidosis is associated with malignant arrhythmias, and athletes with implantable cardioverter-defibrillators (ICDs) have historically been restricted from competition. CASE SUMMARY: A 34-year old professional basketball player experienced cardiac arrest due to monomorphic ventricular tachycardia during competition, however cardiopulmonary resuscitation with automated external defibrillator use led to immediate cardioversion. Work-up revealed findings of probable cardiac sarcoidosis according to current criteria. He was treated with steroids, and an ICD was placed with no further arrhythmia. With shared decision-making, he returned to competition. DISCUSSION: The evaluation of cardiac arrest requires coronary, genetic, and myocardial interrogation, with myocardial processes best evaluated using advanced imaging and, selectively, endomyocardial biopsy. Recent data suggest the safety of ICD use in athletes. TAKE-HOME MESSAGES: The diagnosis of cardiac sarcoidosis relies largely on clinical findings and noninvasive imaging and exists on a spectrum of definite, probable, possible, or unlikely. Return to play after ICD implantation is an important consideration in competitive athletes with sudden cardiac arrest and requires shared decision-making.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.